gamma-Glutamyl-peptides are frequently endowed with biological activities. In this work, "kokumi peptides " such as gamma- glutamyl-methionine (1) and gamma-glutamyl-(S)-allyl-cysteine (2), as well as the neuroprotective gamma-glutamyl-taurine (3) and the antioxidant ophthalmic acid (4), were synthesized through an enzymatic transpeptidation reaction catalyzed by the gamma-glutamyl transferase from Bacillus subtilis (BsGGT) using glutamine as the gamma-glutamyl donor. BsGGT was covalently immobilized on glyoxylagarose resulting in high protein immobilization yield and activity recovery (> 95%). Compounds 1-4 were obtained in moderate yields (19-40%, 5-10 g/L) with a variable purity depending on the presence of the main byproduct (gamma-glutamyl-glutamine, 0-16%). To achieve process intensification and better control of side reactions, the synthesis of 2 was moved from batch to continuous flow. The specific productivity was 1.5 times higher than that in batch synthesis (13.7 mu mol/min*g), but it was not accompanied by a paralleled improvement of the impurity profile.
From Batch to Continuous Flow Bioprocessing: Use of an Immobilized γ-Glutamyl Transferase from B. subtilis for the Synthesis of Biologically Active Peptide Derivatives
Robescu, Marina SInvestigation
;Calvio, CinziaResources
;Ubiali, Daniela;Bavaro, Teodora
Writing – Review & Editing
2022-01-01
Abstract
gamma-Glutamyl-peptides are frequently endowed with biological activities. In this work, "kokumi peptides " such as gamma- glutamyl-methionine (1) and gamma-glutamyl-(S)-allyl-cysteine (2), as well as the neuroprotective gamma-glutamyl-taurine (3) and the antioxidant ophthalmic acid (4), were synthesized through an enzymatic transpeptidation reaction catalyzed by the gamma-glutamyl transferase from Bacillus subtilis (BsGGT) using glutamine as the gamma-glutamyl donor. BsGGT was covalently immobilized on glyoxylagarose resulting in high protein immobilization yield and activity recovery (> 95%). Compounds 1-4 were obtained in moderate yields (19-40%, 5-10 g/L) with a variable purity depending on the presence of the main byproduct (gamma-glutamyl-glutamine, 0-16%). To achieve process intensification and better control of side reactions, the synthesis of 2 was moved from batch to continuous flow. The specific productivity was 1.5 times higher than that in batch synthesis (13.7 mu mol/min*g), but it was not accompanied by a paralleled improvement of the impurity profile.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.